Trial to Assess the Bioavailability of Quetiapine Versus Seroquel® in Subjects With Schizophrenia or Bipolar Disorder

NCT03872596 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

58

Enrollment

INDUSTRY

Sponsor class

Conditions

Bipolar Disorder
Schizophrenia

Interventions

DRUG: Seroquel IR 300mg
DRUG: Seroquel IR 25mg
DRUG: Quetiapine Formulation A 300mg
DRUG: Quetiapine Formulation B 300mg
DRUG: Quetiapine Formulation 25mg

Sponsor

Otsuka Pharmaceutical Development & Commercialization, Inc.

Collaborators

[object Object]